Qiagen N.V. (LON:0RLT)

Market Cap	6.76B
Revenue (ttm)	1.58B
Net Income (ttm)	66.77M
Shares Out	n/a
EPS (ttm)	0.30
PE Ratio	101.32
Forward PE	n/a
Dividend	1.01 (2.70%)
Ex-Dividend Date	Jan 29, 2025

Volume	38,260
Average Volume	75,063
Open	36.95
Previous Close	37.50
Day's Range	36.76 - 37.57
52-Week Range	30.27 - 39.91
Beta	0.36
RSI	20.21
Earnings Date	Feb 3, 2025

About Qiagen

Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids from secondary sample materials; and instruments for n...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,700
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RLT

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD